1. [OP.7A.10] COMMON AND EMERGENT FACTORS ASSOCIATED WITH HYPERTENSION CONTROL IN ROMANIA. (September 2016) Authors: Darabont, R.; Tautu, O.; Ardeleanu, M.; Dorobantu, M. Journal: Journal of hypertension Issue: Volume 34:(2016) Supplement 2 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. A study of dupilumab in the treatment of adolescents with eczema. (1st January 2020) Authors: Cork, M.J.; Thaçi, D.; Eichenfield, L.F.; Arkwright, P.D.; Hultsch, T.; Davis, J.D.; Zhang, Y.; Zhu, X.; Chen, Z.; Li, M.; Ardeleanu, M.; Teper, A.; Akinlade, B.; Gadkari, A.; Eckert, L.; Kamal, M.A.; Ruddy, M.; Graham, N.M.H.; Pirozzi, G.; Stahl, N. Journal: British journal of dermatology Issue: Volume 182:Number 1(2020) Page Start: e30 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. A study of dupilumab in the treatment of adolescents with eczema. (2nd January 2020) Authors: Cork, M.J.; Thaçi, D.; Eichenfield, L.F.; Arkwright, P.D.; Hultsch, T.; Davis, J.D.; Zhang, Y.; Zhu, X.; Chen, Z.; Li, M.; Ardeleanu, M.; Teper, A.; Akinlade, B.; Gadkari, A.; Eckert, L.; Kamal, M.A.; Ruddy, M.; Graham, N.M.H.; Pirozzi, G.; Stahl, N. Journal: British journal of dermatology Issue: Volume 182:Number 1(2020) Page Start: e30 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Assessing the need for routine safety testing for patients being treated with dupilumab for moderate‐to‐severe atopic dermatitis. (1st June 2020) Authors: Wollenberg, A; Beck, L.A.; Blauvelt, A.; Simpson, E.L.; Chen, Z.; Chen, Q.; Shumel, B.; Khokhar, F.A.; Hultsch, T.; Rizova, E.; Rossi, A.B.; Graham, N.M.H.; Pirozzi, G.; Lu, Y.; Ardeleanu, M. Journal: British journal of dermatology Issue: Volume 182:Number 6(2020) Page Start: e186 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Conjunctivitis in dupilumab clinical trials. (1st September 2019) Authors: Akinlade, B.; Guttman‐Yassky, E.; de Bruin‐Weller, M.; Simpson, E.L.; Blauvelt, A.; Cork, M.J.; Prens, E.; Asbell, P.; Akpek, E.; Corren, J.; Bachert, C.; Hirano, I.; Weyne, J.; Korotzer, A.; Chen, Z.; Hultsch, T.; Zhu, X.; Davis, J.D.; Mannent, L.; Hamilton, J.D. Journal: British journal of dermatology Issue: Volume 181:Number 3(2019) Page Start: e69 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Conjunctivitis in dupilumab clinical trials. (7th May 2019) Authors: Akinlade, B.; Guttman‐Yassky, E.; de Bruin‐Weller, M.; Simpson, E.L.; Blauvelt, A.; Cork, M.J.; Prens, E.; Asbell, P.; Akpek, E.; Corren, J.; Bachert, C.; Hirano, I.; Weyne, J.; Korotzer, A.; Chen, Z.; Hultsch, T.; Zhu, X.; Davis, J.D.; Mannent, L.; Hamilton, J.D. Journal: British journal of dermatology Issue: Volume 181:Number 3(2019) Page Start: 459 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Dupilumab in adolescents with uncontrolled moderate‐to‐severe atopic dermatitis: results from a phase IIa open‐label trial and subsequent phase III open‐label extension. (1st January 2020) Authors: Cork, M.J.; Thaçi, D.; Eichenfield, L.F.; Arkwright, P.D.; Hultsch, T.; Davis, J.D.; Zhang, Y.; Zhu, X.; Chen, Z.; Li, M.; Ardeleanu, M.; Teper, A.; Akinlade, B.; Gadkari, A.; Eckert, L.; Kamal, M.A.; Ruddy, M.; Graham, N.M.H.; Pirozzi, G.; Stahl, N. Journal: British journal of dermatology Issue: Volume 182:Number 1(2020) Page Start: 85 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Dupilumab in adolescents with uncontrolled moderate‐to‐severe atopic dermatitis: results from a phase IIa open‐label trial and subsequent phase III open‐label extension. (8th October 2019) Authors: Cork, M.J.; Thaçi, D.; Eichenfield, L.F.; Arkwright, P.D.; Hultsch, T.; Davis, J.D.; Zhang, Y.; Zhu, X.; Chen, Z.; Li, M.; Ardeleanu, M.; Teper, A.; Akinlade, B.; Gadkari, A.; Eckert, L.; Kamal, M.A.; Ruddy, M.; Graham, N.M.H.; Pirozzi, G.; Stahl, N. Journal: British journal of dermatology Issue: Volume 182:Number 1(2020) Page Start: 85 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Dupilumab provides important clinical benefits to patients with atopic dermatitis who do not achieve clear or almost clear skin according to the Investigator's Global Assessment: a pooled analysis of data from two phase III trials. (1st July 2019) Authors: Silverberg, J.I.; Simpson, E.L.; Ardeleanu, M.; Thaçi, D.; Barbarot, S.; Bagel, J.; Chen, Z.; Eckert, L.; Chao, J.; Korotzer, A.; Rizova, E.; Rossi, A.B.; Lu, Y.; Graham, N.M.H.; Hultsch, T.; Pirozzi, G.; Akinlade, B. Journal: British journal of dermatology Issue: Volume 181:Number 1(2019) Page Start: 80 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Dupilumab provides important clinical benefits to patients with atopic dermatitis who do not achieve clear or almost clear skin according to the Investigator's Global Assessment: a pooled analysis of data from two phase III trials. (11th April 2019) Authors: Silverberg, J.I.; Simpson, E.L.; Ardeleanu, M.; Thaçi, D.; Barbarot, S.; Bagel, J.; Chen, Z.; Eckert, L.; Chao, J.; Korotzer, A.; Rizova, E.; Rossi, A.B.; Lu, Y.; Graham, N.M.H.; Hultsch, T.; Pirozzi, G.; Akinlade, B. Journal: British journal of dermatology Issue: Volume 181:Number 1(2019) Page Start: 80 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗